The document provides guidelines on procedures and data requirements for changes to approved biotherapeutic products.
Published by the World Health Organization (WHO), this document serves as a guide for establishing national requirements for the regulation of post-approval changes to biotherapeutic products. It addresses the complexity of managing the life-cycle of these products, covering changes made for routine production, quality improvement, safety, efficacy, or administrative reasons.